ALLE — Allegion plc

The Q2 2026 beat — revenue up 12.7% YoY to $1.1515B, adjusted EPS $2.40 versus $2.22 expected — plus the raise to $8.85-$9.00 EPS guidance created real momentum. But Wall Street still sits mostly at Hold, the consensus target of $156 is slightly below the current price, and International organic revenue remains negative. With RSI at 52.34 and the stock just below its 20-day SMA, sentiment is constructive but not excited.

Revenue growth has clearly accelerated: YoY growth went from roughly +5.4% in Q1 2025 and +5.8% in Q2 2025 to +10.7% in Q3 2025, +9.3% in Q4 2025, +9.7% in Q1 2026, and +12.7% in Q2 2026. Organic growth in Q2 was 6.9%, so part of the reported jump includes acquisition-related contribution. GAAP operating margin in Q2 2026 was 22.1% versus 21.5% a year earlier; Q1 2026 dipped to 18.9% from 20.8%, so quarterly GAAP margins are noisy. The underlying read is that Americas momentum is real and margins are holding up well, while International remains a drag rather than a contributor.

Fair, not cheap. The TTM P/E is 20.85x versus the 5-year average of 21.17x, and P/S is 3.17x versus the 5-year average of 3.28x. On forward EPS of roughly $8.95, the forward P/E is about 17.9x, which is reasonable for a business with 20%-plus operating margins and mid-to-high single-digit organic growth. The TTM PEG of 3.59 is not a useful lens here because it mixes a trailing multiple with distorted trailing growth. Overall, the stock is in line with its own historical valuation band, with no obvious bargain or bubble.

At $159.72, the market is paying about 17.9x forward earnings. That is not pricing in a rapid European recovery or a major multiple expansion; it is mostly paying for the Americas growth story and raised guidance. If Q3 2026 shows Europe stabilizing and Americas growth staying high-single-digit, estimates can grind higher and the stock can work toward $170. If Americas organic growth decelerates or cash flow keeps lagging earnings, $150 becomes the more likely re-test. The Street's $156 consensus target versus the $159.72 price suggests the easy post-earnings repricing has already happened.

As of 2026-08-27, RSI-14 is 52.34, squarely neutral. The stock is 2.41% below its 20-day SMA (roughly $163.70), 6.51% above its 50-day SMA (roughly $150.00), and 5.51% above its 200-day SMA (roughly $151.40). That is a medium-term uptrend with short-term consolidation rather than overbought/oversold. A pullback toward the $150-$152 support zone would be a more attractive entry than chasing the stock here.

• Elevated interest rates continue to pressure parts of commercial construction and legacy mechanical hardware demand.
• The secular shift to electronic access control, software, and recurring revenue supports margins and portfolio quality.
• European macro weakness, especially Germany, is dragging the International segment, with organic revenue down 1.2%.
• Resilient U.S. institutional demand from education, healthcare, multi-family, and data centers is underpinning Americas growth.
• Price realization and productivity gains have helped Allegion offset input-cost inflation.

• Q3 2026 earnings in late October 2026: investors will look for European demand stabilization and continued Americas margin strength.
• Continued mix shift toward electronic access control and new products like the Schlage XE360 and Sense Pro, supporting growth and recurring revenue.
• Capital allocation and integration of recent M&A such as Elatec and Gatewise, which could add to the electronic/software ecosystem.
• Any pivot toward lower interest rates would improve non-residential construction sentiment and help the International segment.

• International weakness persists or worsens, particularly in Germany and broader Europe.
• High borrowing costs delay commercial construction projects and weigh on mechanical hardware volumes.
• Operating cash flow lagged earnings in Q2 2026 — Q2 OCF fell roughly 10.6% YoY despite earnings growth; if that persists, quality concerns could emerge.
• Competition in smart-access and electronic security could pressure pricing, and FX or input-cost swings could hurt margins.
• The stock trades slightly above the consensus price target, leaving limited near-term upside without estimate upgrades.

Allegion is a high-quality industrials franchise with strong Americas momentum, 20%+ operating margins, negative accruals, and a fair valuation. The offsetting factors — negative International growth, softer Q2 cash flow, and a Street target below the current price — keep the risk/reward balanced. I would call it a hold at $159.72 rather than a compelling buy; a move toward $150 or evidence of European stabilization would make it more attractive.

I applied a 19.0x forward P/E to forward EPS of $8.95 (FY26 guidance midpoint/analyst average), a modest discount to ALLE's 5-year average P/E of 21.17x to reflect Europe weakness and the Street's Hold stance. That produces $170.05, implying a reasonable ~6.5% upside from the 2026-08-27 price.